Effects of oral and intravenous tranexamic acid on perioperative blood loss after lumbar spinal canal decompression and fusion.
10.12200/j.issn.1003-0034.2022.08.007
- Author:
Mei-Tao QI
1
;
Shu-Ying WANG
1
;
Ling-Ting WANG
1
;
Xue-Wu CHEN
1
;
Wen-Hao ZHAN
1
;
Xiao-Feng ZHU
1
;
Hong WANG
1
Author Information
1. Department of Spine Orthopaedics, Yijishan Hospital, Wannan Medical College, Wuhu 241000, Anhui, China.
- Publication Type:Journal Article
- Keywords:
Hemorrhage;
Lumbar vertebrae;
Perioperative period;
Tranexamic acid
- MeSH:
Antifibrinolytic Agents/therapeutic use*;
Blood Loss, Surgical/prevention & control*;
Decompression;
Humans;
Postoperative Hemorrhage;
Spinal Canal;
Spinal Fusion/methods*;
Tranexamic Acid/therapeutic use*;
Venous Thrombosis/etiology*
- From:
China Journal of Orthopaedics and Traumatology
2022;35(8):736-739
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effects of different administration methods of tranexamic acid(TXA) on the perioperative blood loss, hidden blood loss, transfusion rate and adverse reactions in lumbar spinal decompression and fusion.
METHODS:Sixty patients who received lumbar spinal canal decompression and fusion from July 2019 to July 2020 were enrolled and divided into observation group and control group, with 30 cases in each group. The observation group was given 2 g TXA orally at 2 hours before operation, control group was given 1 g TXA for 5-10 min before skin incision and 6 hours after operation intravenously. The intraoperative blood loss, postoperative drainage, total blood loss, hidden blood loss, drainage tube removal time, blood transfusion rate, venous thrombosis rate, adverse event rate were recorded respectively. The changes of hemoglobin(Hb) and hematocrit (HCT) were observed before operation and 1, 3 days after operation.
RESULTS:Hb and HCT at 1 and 3 days after operation were significantly improved compared with those before operation(P<0.01). However, there was no significant difference between the groups(P>0.05). There were no significant difference in amount of blood loss, postoperative drainage, total blood loss, intraoperative blood loss, hidden blood loss, postoperative drainage time, and blood transfusion rate between two groups (P>0.05). There were no venous thrombosis and adverse events occurred in both groups.
CONCLUSION:During the perioperative period of lumbar spinal decompression and fusion, oral TXA and intravenous TXA have the same effect in reducing perioperative blood loss and are safe and reliable. It is recommended that oral TXA be used to save medical costs and convenience.
